Home
JL

JLoJI jIjc

American Stocks Program

5681
Tracked News
Latest live feed
454
Opportunities
Gold: 35 | Early: 272
0
ENTER + STALK Now
ENTER: 0 | STALK: 0
10
READY to Execute
Early total: 272
Latest News View All
POOL
[SEC 8-K] Item 2.02: Results of Operations and Financial Condition | Item 7.01: Regulation FD Disclosure | Item 9.01: Fi…
GENERAL 2026-04-23T09:42:49-04:00
ALBT
+5 Dow Gains Over 200 Points; US Retail Sales Top Estimates US stocks up as Dow Jones gains 0.48% and NASDAQ rises 0.03%…
GENERAL 2026-04-21 13:42:06
MNSBP
[SEC 8-K] Item 8.01: Other Events
GENERAL 2026-04-21T09:38:23-04:00
IFRX
Guggenheim Reiterates Buy on InflaRx, Maintains $14 Price Target Guggenheim analyst Yatin Suneja reiterates InflaRx (NAS…
GENERAL 2026-04-21 13:39:11
MLSS
[SEC 8-K] Item 1.01: Entry into a Material Definitive Agreement | Item 3.02: Unregistered Sales of Equity Securities | I…
MNA 2026-04-21T09:36:42-04:00
ASRV
[SEC 8-K] Item 2.02: Results of Operations and Financial Condition | Item 8.01: Other Events | Item 9.01: Financial Stat…
GENERAL 2026-04-21T09:31:37-04:00
MMEX
[SEC 8-K] Item 3.02: Unregistered Sales of Equity Securities
GENERAL 2026-04-21T09:30:34-04:00
ALT
Why Is Altimmune Stock Falling Today? Altimmune shares fall after a $225 million offering raises dilution concerns while…
FDA 2026-04-23 13:30:41
HLLY
Holley Launches High-Performance Car Care in Partnership with Malco Automotive
FDA 2026-04-21 13:30:05
XRTX
XORTX Therapeutics shares are trading higher after the company announced that it regained Nasdaq compliance.
GENERAL 2026-04-21 13:29:15
Top Opportunities View All (454)
WATCH ALLO
Allogene Therapeutics Receive South Korea, Australia Clearance To Expa…
2.59% | fda | ks=95
WATCH ENLV
Enlivex Announces Second Regulatory Approval From Danish Medicines Age…
2.42% | fda | ks=95
WATCH PLYX
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 f…
3.8% | fda | ks=87
WATCH BCDA
Japan's Pharmaceutical and Medical Device Agency Finds BioCardua's Car…
2.46% | fda | ks=85
WATCH SLE
Super League Publishes Letter Urging Shareholders To Support Acquisiti…
1.97% | mna | ks=85
Gold Picks View All (35)
ALERT HUMA
Humacyte Announces Marketing Approval For Symvess Vascular Trauma…
9.26% | fda | ks=85
WATCH ENLV
Enlivex Announces Second Regulatory Approval From Danish Medicine…
2.42% | fda | ks=95
WATCH ALLO
Allogene Therapeutics Receive South Korea, Australia Clearance To…
2.59% | fda | ks=95
Early Signals View All (272)
READY HUMA
Humacyte Announces Marketing Approval For Symvess Vascular Trauma…
9.26% | score=105
READY ALLO
Allogene Therapeutics Receive South Korea, Australia Clearance To…
2.59% | score=103
READY ENLV
Enlivex Announces Second Regulatory Approval From Danish Medicine…
2.42% | score=103
READY PLYX
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑…
3.8% | score=101